Intersect ENT
XENT
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)
Categories
Market capitalization of Intersect ENT (XENT)
Market cap: $0.95 Billion
As of April 2024 Intersect ENT has a market cap of $0.95 Billion. This makes Intersect ENT the world's 5133th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Intersect ENT from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.95 B | |
| 2022 | $0.95 B | 4.49% |
| 2021 | $0.91 B | 21.16% |
| 2020 | $0.75 B | -6.03% |
| 2019 | $0.80 B | -7.36% |
| 2018 | $0.86 B | -9.22% |
| 2017 | $0.95 B | 176.12% |
| 2016 | $0.34 B | -45.45% |
| 2015 | $0.63 B | 46.09% |
| 2014 | $0.43 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | $0.77 B | -18.75% | 🇺🇸 USA |
 ICON plc ICLR | $23.77 B | 2,390.06% | 🇮🇪 Ireland |
 Anika Therapeutics ANIK | $0.38 B | -59.82% | 🇺🇸 USA |
 Haemonetics HAE | $4.12 B | 332.07% | 🇺🇸 USA |